title: Clinical development success rates for investigational drugs.
authors.affiliation: BioMedTracker, Sagient Research Systems, San Diego, California, USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Hay
authors.affiliation: Biotechnology Industry Organization (BIO), Washington, DC, USA.
authors.forename: David W
authors.initials: DW
authors.lastname: Thomas
authors.affiliation: Biotech Strategy & Analytics, Rockville, Maryland, USA.
authors.forename: John L
authors.initials: JL
authors.lastname: Craighead
authors.affiliation: Biotechnology Industry Organization (BIO), Washington, DC, USA.
authors.forename: Celia
authors.initials: C
authors.lastname: Economides
authors.affiliation: BioMedTracker, Sagient Research Systems, San Diego, California, USA.
authors.forename: Jesse
authors.initials: J
authors.lastname: Rosenthal
mesh_terms: D035843:Biomedical Research; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence
chemical_list: D015507:Drugs, Investigational